Inkon Life Tech Co. Ltd. (300143)
XSHE XSHE Primary Summary
300143 Chart
People also search for
Inkon Life Tech Co. Ltd. (300143) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Inkon Life Tech Co. Ltd. ever had a stock split?
Inkon Life Tech Co. Ltd. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Wen Peng CEO | XSHE Exchange | CNE100000XF6 ISIN |
| CN Country | 2,207 Employees | 3 Jun 2026 Last Dividend | 3 Jun 2026 Last Split | 9 Dec 2010 IPO Date |
Overview
INKON Life Technology Co., Ltd., previously known as Starmap Medicine and Technology Co., Ltd., is a pioneering entity dedicated to enhancing the medical services ecosystem, focusing on a comprehensive care approach encompassing pre-diagnosis, treatment, and health maintenance specifically for tumor-related conditions. The company has expanded its span beyond China, offering international services in its specialty area. The rebranding in July 2019 marked a significant milestone in its journey since its inception in 1998, solidifying its commitment to health innovation. With its headquarters situated in Qingdao, China, INKON Life Technology Co., Ltd. continues to push the boundaries of medical research, development, and the implementation of futuristic technologies in healthcare.
Products and Services
- Ecological Platform for Tumor Care
- Research and Development
- Scenario and Equipment Medical Devices
An integrated solution provided by INKON Life Technology comprises a full spectrum of services targeting tumor-related healthcare. This platform ensures a seamless transition between critical stages of healthcare: pre-diagnosis, active treatment, and ongoing health maintenance. By addressing each phase with dedicated resources and expert insights, INKON facilitates a comprehensive care path for tumor patients.
INKON Life Technology stands at the forefront of medical innovation with its robust focus on the research and development of advanced medical devices and scenarios. This aspect of their operation is dedicated to pushing the conventional boundaries of medical technology, aiming to bring about groundbreaking tools and methodologies for better healthcare outcomes, particularly in the realm of oncology.
The company specializes in the innovation and provision of scenario-based medical devices and equipment. These products are designed with the aim of enhancing healthcare delivery for tumors, making use of cutting-edge technology to create scenarios in which patients can receive more personalized, effective, and efficient treatment and care.
